Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-03-28

Clinical Trial Update: Propranolol in Primary Progressive Aphasia [EARLY_Phase 1]

View source ↗

Summary

A clinical trial is investigating propranolol for primary progressive aphasia in an early-phase 1 study, and recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Propranolol (propranolol)

Snippet

Sponsor: University of Missouri-Columbia | Conditions: Aphasia, Primary Progressive | EARLY_Phase 1 | Status: RECRUITING